US5069911A
(en)
*
|
1985-02-05 |
1991-12-03 |
Sandoz Ltd. |
Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
|
US6468561B1
(en)
*
|
1986-06-19 |
2002-10-22 |
Bpsi Holdings, Inc. |
Aqueous film coating with improved properties
|
EP0261719A3
(de)
*
|
1986-09-23 |
1990-10-10 |
Akzo N.V. |
Thermochemischlumineszierende Komplexe von Cyclodextrinen
|
YU43290B
(en)
*
|
1986-11-13 |
1989-06-30 |
Lek Tovarna Farmacevtskih |
Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine
|
NZ225045A
(en)
*
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
US5068226A
(en)
*
|
1987-12-07 |
1991-11-26 |
Cyclex, Inc. |
Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
|
US5017566A
(en)
*
|
1987-12-30 |
1991-05-21 |
University Of Florida |
Redox systems for brain-targeted drug delivery
|
US5002935A
(en)
*
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
YU45837B
(sh)
*
|
1988-01-18 |
1992-07-20 |
LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. |
Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
|
US5637575A
(en)
*
|
1988-01-19 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Methods of inhibiting restenosis
|
US5760015A
(en)
*
|
1988-01-19 |
1998-06-02 |
The Trustees Of The University Of Pennsylvania |
Cyclodextrin compounds and methods of making and use thereof
|
US5658894A
(en)
*
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
US5019562A
(en)
*
|
1988-01-19 |
1991-05-28 |
The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation |
Growth inhibiting agent and the use thereof
|
CA1321192C
(en)
*
|
1988-04-20 |
1993-08-10 |
Abdul Majid |
Inclusion complexes of cyclodextrins by agglomeration
|
DE3815902A1
(de)
*
|
1988-05-10 |
1989-11-23 |
Schwarz Pharma Gmbh |
Einschlussverbindungen des 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl) -phenylsulfonyl)-3-cyclohexylharnstoffs mit (alpha)-,ss-,(gamma)-cyclodextrinen, jeweils diese enthaltendes pharmazeutisches praeparat und verfahren zu deren herstellung
|
GB8813064D0
(en)
|
1988-06-02 |
1988-07-06 |
Euro Celtique Sa |
Controlled release dosage forms having defined water content
|
JPH01308232A
(ja)
*
|
1988-06-03 |
1989-12-12 |
Takeda Chem Ind Ltd |
固型医薬およびその製造法
|
GB8813682D0
(en)
*
|
1988-06-09 |
1988-07-13 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions
|
GB8814726D0
(en)
*
|
1988-06-21 |
1988-07-27 |
Glaxo Group Ltd |
Medicaments
|
WO1990001320A1
(en)
*
|
1988-08-15 |
1990-02-22 |
American Maize-Products Company |
Water soluble branched beta cyclodextrin steroid complex
|
US5229370A
(en)
*
|
1988-08-15 |
1993-07-20 |
Ammeraal Robert N |
Water soluble branched beta cyclodextrin steroid complex
|
JPH082781B2
(ja)
*
|
1988-10-18 |
1996-01-17 |
嘉明 川島 |
中空顆粒状医薬及びその製法
|
AU616571B2
(en)
*
|
1988-10-28 |
1991-10-31 |
Shiseido Company Ltd. |
Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
|
US5068227A
(en)
*
|
1989-01-18 |
1991-11-26 |
Cyclex, Inc. |
Cyclodextrins as carriers
|
IT1229517B
(it)
*
|
1989-01-31 |
1991-09-03 |
Bioresearch Spa |
Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
|
DE3933000A1
(de)
*
|
1989-10-03 |
1991-04-11 |
Int Pharma Agentur |
Erosionsgesteuertes wirkstoff-freigabesystem und verfahren zu seiner herstellung
|
US5441944A
(en)
*
|
1989-04-23 |
1995-08-15 |
The Trustees Of The University Of Pennsylvania |
Substituted cyclodextrin sulfates and their uses as growth modulating agents
|
FR2647343B1
(fr)
*
|
1989-05-24 |
1994-05-06 |
Rhone Poulenc Sante |
Nouvelle forme pharmaceutique poreuse et sa preparation
|
FR2647304B1
(fr)
*
|
1989-05-29 |
1994-07-08 |
Roquette Freres |
Composition phytosanitaire, son procede de preparation et son utilisation, en particulier pour lutter contre le mildiou de la vigne
|
DK169306B1
(da)
*
|
1989-06-14 |
1994-10-10 |
Af 18 Juni 1990 As |
Middel til fjernelse eller inaktivering af uønskede komponenter i blod eller andre ekstracellulære legemsvæsker samt fremgangsmåde til fremstilling af dextran-O-carbonyl-benzo-18-crown-6 og af dextran-hydroxyethylbenzo-18-crown-6
|
IT1241673B
(it)
*
|
1989-10-09 |
1994-01-27 |
Istituto Biochimico Italiano |
Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
|
US4983399A
(en)
*
|
1989-10-18 |
1991-01-08 |
Eastman Kodak Company |
Direct compression carrier composition
|
IE63986B1
(en)
*
|
1989-12-30 |
1995-06-28 |
Akzo Nv |
Pharmaceutical preparation for oral administration in fluid form
|
HU212730B
(en)
*
|
1990-03-28 |
1996-10-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
|
HU210921B
(en)
*
|
1990-03-28 |
1995-09-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
|
US5246611A
(en)
*
|
1990-05-09 |
1993-09-21 |
The Procter & Gamble Company |
Non-destructive carriers for cyclodextrin complexes
|
US5384186A
(en)
*
|
1990-05-09 |
1995-01-24 |
The Proctor & Gamble Company |
Non-destructive carriers for cyclodextrin complexes
|
ES2023552A6
(es)
*
|
1990-05-22 |
1992-01-16 |
Leetrim Limited |
Procedimiento para la preparacion de compuestos de inclusion de nimesulida con ciclodextrina.
|
FR2665158B1
(fr)
*
|
1990-07-30 |
1993-12-24 |
Air Liquide |
Clathrates de peroxyacides.
|
US5180716A
(en)
*
|
1990-08-01 |
1993-01-19 |
The Regents Of The University Of California |
Cyclodextrin complexes for neuraxial administration of drugs
|
IT1243192B
(it)
*
|
1990-08-09 |
1994-05-24 |
Staroil Ltd |
Complessi di acidi grassi polinsaturi a lunga catena e di loro derivati, con ciclodestrine
|
US5292520A
(en)
*
|
1990-09-13 |
1994-03-08 |
Akzo N.V. |
Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
|
US5238927A
(en)
*
|
1990-11-30 |
1993-08-24 |
Brown Nesbitt D |
Hydrolytic stabilizer for unstable organic ions
|
US5258370A
(en)
*
|
1991-04-04 |
1993-11-02 |
Curators Of The University Of Missouri |
Artificial redox enzymes
|
JP2538134B2
(ja)
*
|
1991-04-08 |
1996-09-25 |
田辺製薬株式会社 |
徐放性製剤およびその製造法
|
US5321014A
(en)
*
|
1991-06-28 |
1994-06-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
|
US5164379A
(en)
*
|
1991-07-15 |
1992-11-17 |
Bristol-Myers Company |
Sucralfate/cyclodextrin complexes
|
AT400674B
(de)
*
|
1991-07-24 |
1996-02-26 |
Biochemie Gmbh |
Pharmazeutische pleuromutilin-zubereitung
|
US5446030A
(en)
*
|
1991-09-19 |
1995-08-29 |
Weisz; Paul B. |
Prevention of hemolysis
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
DE4204315A1
(de)
*
|
1992-02-13 |
1993-08-19 |
Consortium Elektrochem Ind |
Cyclodextringlycoside und verfahren zu ihrer herstellung
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
HU209251B
(en)
*
|
1992-03-13 |
1994-04-28 |
Synepos Ag |
Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
|
US5472954A
(en)
*
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
US5324718A
(en)
*
|
1992-07-14 |
1994-06-28 |
Thorsteinn Loftsson |
Cyclodextrin/drug complexation
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
CN1039585C
(zh)
*
|
1993-01-01 |
1998-08-26 |
生化企业 |
截短侧耳素衍生物与环糊精的配合物和含有它的药物制剂
|
USRE39300E1
(en)
|
1993-01-28 |
2006-09-19 |
Virginia Commonwealth University Medical College Of Virginia |
Inhibiting the development of tolerance to and/or dependence on an addictive substance
|
US5321012A
(en)
*
|
1993-01-28 |
1994-06-14 |
Virginia Commonwealth University Medical College |
Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
|
US5362860A
(en)
*
|
1993-02-01 |
1994-11-08 |
Warner-Lambert Company |
Neutral stabilization complex for CI-979 HCl, a cognition activator
|
WO1994018973A1
(en)
*
|
1993-02-26 |
1994-09-01 |
The Procter & Gamble Company |
Bisacodyl dosage form
|
US5656290A
(en)
*
|
1993-02-26 |
1997-08-12 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
US5843479A
(en)
*
|
1993-02-26 |
1998-12-01 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
US5651983A
(en)
*
|
1993-02-26 |
1997-07-29 |
The Procter & Gamble Company |
Bisacodyl dosage form for colonic delivery
|
US5914132A
(en)
*
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
DK0865789T3
(da)
*
|
1993-03-26 |
2005-07-18 |
Franciscus Wilhelmus He Merkus |
Farmaceutiske præparater til intranasal administration af dihydroergotamin
|
EP0697874A1
(de)
*
|
1993-03-31 |
1996-02-28 |
The Trustees Of The University Of Pennsylvania |
Verfahren zur beeinflussung des wachstums von lebendem gewebe in säugetieren und verbindungen und präparate hierfür
|
NZ260408A
(en)
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US20060263428A1
(en)
*
|
1993-09-20 |
2006-11-23 |
Eugenio Cefali |
Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
|
US6129930A
(en)
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US6676967B1
(en)
*
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5516524A
(en)
*
|
1993-12-20 |
1996-05-14 |
The Procter & Gamble Company |
Laxative compositions containing bulk fiber
|
US5480975A
(en)
*
|
1994-02-08 |
1996-01-02 |
Brigham And Women's Hospital |
Induction of vascular endothelial growth factor (VEGF) by transition metals
|
PL180465B1
(pl)
*
|
1994-03-02 |
2001-02-28 |
Akzo Nobel Nv |
Kompozycja farmaceutyczna zawierajaca trans-5-chloro-2-metylo-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-c]pirol PL PL PL
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
EP0672416A1
(de)
*
|
1994-03-14 |
1995-09-20 |
Euro-Celtique S.A. |
Diamorphin enthaltendes Arzneimittel
|
US5938990A
(en)
*
|
1994-07-01 |
1999-08-17 |
Roche Vitamins Inc. |
Encapsulation of oleophilic substances and compositions produced thereby
|
DE4432757A1
(de)
*
|
1994-09-14 |
1996-03-21 |
Boehringer Mannheim Gmbh |
Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US20020006438A1
(en)
*
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US5904935A
(en)
*
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
US5931809A
(en)
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
US5744154A
(en)
*
|
1995-09-06 |
1998-04-28 |
Laboratoire Chauvin S.A. |
Ready-to-use indomethacin-based eye lotion
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
IT1276130B1
(it)
|
1995-11-14 |
1997-10-27 |
Gentili Ist Spa |
Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
|
HUT75956A
(en)
*
|
1995-11-29 |
1997-05-28 |
Cyclolab |
Pharmaceutical composition containing thyroxine
|
US5942501A
(en)
*
|
1996-08-16 |
1999-08-24 |
Collaborative Laboratories, Inc. |
Cyclodextrin derivative complex
|
EP0934341A1
(de)
*
|
1996-10-28 |
1999-08-11 |
Farmac Nederland B.V. |
Einschlusskomplexe von beta-2-adrenergika zur oralen mukosalen abgabe
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
US20060002959A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Government Of The United States |
Skin-sctive adjuvants for transcutaneous immuization
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
CA2254078A1
(en)
*
|
1997-03-11 |
1998-09-17 |
Hexal Ag |
Solid, non-deliquescent formulations of sodium valproate
|
US6046177A
(en)
*
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
US6074674A
(en)
*
|
1997-10-31 |
2000-06-13 |
University Of Kentucky Research Foundation |
Formulations for sustained-release of topical anesthetics and methods of making and using same
|
US20040258703A1
(en)
*
|
1997-11-14 |
2004-12-23 |
The Government Of The Us, As Represented By The Secretary Of The Army |
Skin-active adjuvants for transcutaneous immunization
|
UA53774C2
(uk)
*
|
1997-12-22 |
2003-02-17 |
Еро-Селтік, С.А. |
Спосіб запобігання зловживанню лікарськими формами, що містять опіоїди
|
RU2241458C2
(ru)
|
1997-12-22 |
2004-12-10 |
Эро-Селтик, С.А. |
Комбинации агонист/антагонист опиоида
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
EP2368575B1
(de)
*
|
1999-04-08 |
2014-10-01 |
Intercell USA, Inc. |
Trockenformulierung für transkutane immunisierung
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
EP2295043A1
(de)
|
1999-10-29 |
2011-03-16 |
Euro-Celtique S.A. |
Hydrocodon-Formulierungen mit gesteuerter Freisetzung
|
TWI242015B
(en)
|
1999-11-29 |
2005-10-21 |
Akzo Nobel Nv |
6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
|
SI2517710T1
(sl)
|
2000-02-08 |
2015-07-31 |
Euro-Celtique S.A. |
Oralne formulacije opioidnih agonistov, varne pred zlorabo
|
SK282717B6
(sk)
*
|
2000-03-10 |
2002-11-06 |
�Stav Experiment�Lnej Farmakol�Gie Sav |
Spôsob prípravy ultravysokomolekulových hyalurónanov
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
US6676966B1
(en)
|
2000-05-09 |
2004-01-13 |
Intellipharmaceutics Corp. |
Extended release metformin hydrochloride formulations
|
US6855721B1
(en)
|
2000-07-28 |
2005-02-15 |
Indevus Pharmaceuticals, Inc. |
Methods and compositions for alleviating stuttering
|
SE0003125D0
(sv)
*
|
2000-09-05 |
2000-09-05 |
Astrazeneca Ab |
Modified polymers
|
KR101167465B1
(ko)
|
2000-10-30 |
2012-07-27 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
AU2002220248A1
(en)
*
|
2000-11-06 |
2002-05-15 |
Andrx Pharmaceuticals, Inc. |
Once a day antihistamine and decongestant formulation
|
DE60227157D1
(de)
*
|
2001-02-13 |
2008-07-31 |
Us Gov Sec Army |
Impstoffe zur transkutanen immunisierung gegen reisediarrhö
|
BR0102252B1
(pt)
*
|
2001-04-10 |
2013-10-22 |
|
Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
JP4522652B2
(ja)
|
2001-05-11 |
2010-08-11 |
エンドー ファーマシューティカルズ, インコーポレイティド |
乱用防止制御放出オピオイド投薬形態
|
WO2002094324A1
(en)
*
|
2001-05-18 |
2002-11-28 |
Institute Of Materials Research & Engineering |
Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
|
US7052706B2
(en)
*
|
2001-06-08 |
2006-05-30 |
Nostrum Pharmaceuticals, Inc. |
Control release formulation containing a hydrophobic material as the sustained release agent
|
US6524618B1
(en)
|
2001-06-12 |
2003-02-25 |
Vijai Kumar |
Directly compressible extended-release matrix formulation for metformin hydrochloride
|
AU2002316738B2
(en)
*
|
2001-07-18 |
2009-01-08 |
Euro-Celtique S.A. |
Pharmaceutical combinations of oxycodone and naloxone
|
US20030157168A1
(en)
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
MXPA04001210A
(es)
|
2001-08-06 |
2004-07-08 |
Euro Celtique Sa |
Formulaciones de agonista opioide con antagonista liberable y aislado.
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
DE60218885T2
(de)
|
2001-11-30 |
2008-01-17 |
Pfizer Products Inc., Groton |
Orale pharmazeutische Arzneiformen bzw. Dosierungsformen von 5,8,14-Triazatetra-cyclo-(10.3.1.0 (2,11).0(4,9)-hexadeca-2(11),3,5,7,9-pentaen mit kontrollierter Freisetzung
|
JP4620355B2
(ja)
|
2002-04-05 |
2011-01-26 |
ユーロ−セルティーク エス.エイ. |
活性化合物の持続、不変及び独立放出のためのマトリクス
|
EP1515701B1
(de)
|
2002-06-17 |
2014-09-17 |
Inventia Healthcare Private Limited |
Verfahren zur herstellung von mehrschichtigen tabletten die thiazolidinedione und biguanide enthalten
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
NZ570198A
(en)
*
|
2002-07-29 |
2010-01-29 |
Alza Corp |
Methods and dosage forms for controlled delivery of paliperidone or risperidone
|
CA2494281A1
(en)
|
2002-08-02 |
2004-02-12 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
CN1703200B
(zh)
|
2002-09-20 |
2012-02-29 |
奥尔制药公司 |
隔离亚单元和相关组合物及方法
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
US8092831B2
(en)
*
|
2002-11-08 |
2012-01-10 |
Andrx Pharmaceuticals, Llc |
Antihistamine and decongestant system
|
US20040156893A1
(en)
*
|
2003-02-11 |
2004-08-12 |
Irwin Klein |
Method for treating hypothyroidism
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
MY135852A
(en)
*
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
ES2336913T3
(es)
*
|
2003-08-08 |
2010-04-19 |
Biovail Laboratories International Srl |
Comprimido de liberacion modificada de hidrocloruro de bupropion.
|
US20050202079A1
(en)
*
|
2004-03-15 |
2005-09-15 |
Mylan Pharmaceuticals Inc. |
Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
|
GB0408308D0
(en)
|
2004-04-14 |
2004-05-19 |
Vectura Ltd |
Pharmaceutical compositions
|
CA2564731A1
(en)
|
2004-04-27 |
2005-11-10 |
Medicinova, Inc. |
Phenoxyalkycarboxylic acid derivatives in the treatment of inflammatory diseases
|
US7691874B2
(en)
*
|
2004-05-14 |
2010-04-06 |
Hyoung-Chun KIM |
Neuroprotective properties of dextrorotatory morphinans
|
EP1604666A1
(de)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
|
CA2574491C
(en)
*
|
2004-07-19 |
2011-05-24 |
Onconova Therapeutics, Inc. |
Formulations for parenteral administration of (e)-2,6-dialkoxystryryl 4-substituted benzylsulfones
|
EP1702558A1
(de)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Verfahren und Vorrichtung zur Darmtätigkeitserfassung
|
EP1909775B1
(de)
*
|
2005-07-29 |
2012-05-16 |
Onconova Therapeutics, Inc. |
Formulierung strahlenschützender, alpha, beta ungesättigter arylsulfone
|
JP4783098B2
(ja)
*
|
2005-09-09 |
2011-09-28 |
リンテック株式会社 |
擬ポリロタキサンおよびポリロタキサンの製造方法
|
US20070281017A1
(en)
*
|
2006-06-06 |
2007-12-06 |
Endo Pharmaceuticals Inc., A Delaware Corporation |
Sustained release oxycodone composition with acrylic polymer and metal hydroxide
|
DK2719378T3
(en)
|
2006-06-19 |
2016-10-17 |
Alpharma Pharmaceuticals Llc |
pharmaceutical compositions
|
WO2008011596A2
(en)
*
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophilic abuse deterrent delivery system
|
WO2008105808A2
(en)
*
|
2006-07-28 |
2008-09-04 |
Onconova Therapeutics, Inc. |
FORMULATIONS OF RADIOPROTECTIVE α, β UNSATURATED ARYL SULFONES
|
US20080026054A1
(en)
*
|
2007-04-27 |
2008-01-31 |
Nectid Inc. |
Novel anelgesic combination
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
MX2008004268A
(es)
*
|
2008-03-28 |
2009-09-28 |
Posi Visionary Solutions Llp |
Metoclopramida de liberacion prolongada de 24 horas.
|
MX2008004267A
(es)
*
|
2008-03-28 |
2009-09-28 |
Posi Visionary Solutions Llp |
Metoclopramida de liberacion prolongada de 12 horas.
|
PE20110422A1
(es)
*
|
2008-07-07 |
2011-07-01 |
Euro Celtique Sa |
Composicion farmaceutica que comprende antagonistas opioides
|
PT2405915T
(pt)
|
2009-03-10 |
2019-01-29 |
Euro Celtique Sa |
Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
|
CA2692211C
(en)
*
|
2009-12-14 |
2011-09-13 |
Cellresin Technologies, Llc |
Maturation or ripening inhibitor release from polymer, fiber, film, sheet or packaging
|
KR101486691B1
(ko)
|
2011-03-27 |
2015-01-26 |
셀레신 테크놀로지스,엘엘씨 |
사이클로덱스트린 조성물, 물품, 및 방법
|
US10182567B2
(en)
|
2011-03-27 |
2019-01-22 |
Cellresin Technologies, Llc |
Cyclodextrin compositions, articles, and methods
|
US8835499B2
(en)
|
2011-12-08 |
2014-09-16 |
Medicinova, Inc. |
Method of treating non-alcoholic fatty liver disease and steatohepatitis
|
US8962687B2
(en)
|
2012-12-05 |
2015-02-24 |
Medicinova, Inc. |
Method of treating liver disorders
|
US9320288B2
(en)
|
2012-11-30 |
2016-04-26 |
Cellresin Technologies, Llc |
Controlled release compositions and methods of using
|
AU2014295042B2
(en)
|
2013-07-23 |
2017-03-30 |
Mundipharma Pty Limited |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
US20150031769A1
(en)
|
2013-07-25 |
2015-01-29 |
Medicinova, Inc. |
Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels
|
US20150321989A1
(en)
|
2014-05-08 |
2015-11-12 |
Medicinova, Inc. |
Method of treating idiopathic pulmonary fibrosis
|
US9346754B2
(en)
|
2014-05-08 |
2016-05-24 |
Medicinova, Inc. |
Method of treating advanced non-alcoholic steatohepatitis
|
EP3148523B1
(de)
|
2014-06-02 |
2023-08-16 |
MediciNova, Inc. |
Verfahren zur hemmung der behandlung von fibrose
|
US9421793B2
(en)
|
2014-06-26 |
2016-08-23 |
Cellresin Technologies, Llc |
Electrostatic printing of cyclodextrin compositions
|
JP6827924B2
(ja)
|
2014-11-26 |
2021-02-10 |
メディシノバ・インコーポレイテッドMediciNova, Inc. |
イブジラスト及びリルゾールの組み合わせを含む医薬および組成物
|
EP3318252A1
(de)
*
|
2016-11-08 |
2018-05-09 |
Alpex Pharma SA |
Tablette mit verlängerter freisetzung mit einem arzneimittel zur gewichtsabnahme
|
CN111067906B
(zh)
*
|
2020-01-13 |
2022-09-09 |
苏州大学 |
美普他酚的应用
|
CA3217719A1
(en)
|
2021-05-28 |
2022-12-01 |
Kazuko Matsuda |
Phenoxyalkylcarboxylic acid derivatives and their use in lowering triglyceride levels
|